HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors involved in extracellular matrix turnover in human derived cardiomyocytes.

AbstractBACKGROUND:
The molecular mechanisms by which myocardial ischemia translates into ventricular remodeling remain unclear.
METHODS:
We investigated whether hypoxia and proinflammatory cytokines are specific inducers of remodeling signals in an in vitro model of cultured adult human ventricular myocytes (AC16 cells).
RESULTS:
Hypoxia modified the ratio of matrix remodeling factors by increasing the aminoterminal propeptide of type III procollagen (PIIINP) and reducing tissue inhibitor of matrix metalloproteinase type 1 (TIMP-1) secretion in AC16 cells. These effects, however, were not associated with either modifications in expression of matrix metalloproteinase type 2, collagen-I or metalloproteinase activity. Hypoxia does, actually increase the production of the cardiac antifibrogenic growth factors, Apelin and VEGF, through an Hypoxia Inducible Factor type 1-dependent mechanism. Concerning proinflammatory signaling pathways, IL1β emerged as a powerful inducer of matrix turnover, since it significantly enhanced PIIINP, TIMP-1 and hyaluronic acid production and increased metalloproteinase activity. In contrast, TNFα did not modify matrix turnover but markedly induced the production of Apelin and VEGF.
CONCLUSION:
Hypoxia and increased TNFα activity likely exert cardioprotective actions by activating the cardiac antifibrogenic factors Apelin and VEGF. In contrast, IL1β is a strong promoter of interstitial collagen remodeling that may contribute to ventricular dilation and heart failure in the ischemic myocardium.
AuthorsGregori Casals, Guillermo Fernández-Varo, Pedro Melgar-Lesmes, Santi Marfà, Vedrana Reichenbach, Manuel Morales-Ruiz, Wladimiro Jiménez
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 32 Issue 5 Pg. 1125-36 ( 2013) ISSN: 1421-9778 [Electronic] Germany
PMID24247107 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 S. Karger AG, Basel.
Chemical References
  • APLN protein, human
  • Apelin
  • Collagen Type III
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1beta
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinase 2
Topics
  • Apelin
  • Cell Hypoxia (physiology)
  • Cells, Cultured
  • Collagen Type III (genetics, metabolism)
  • Extracellular Matrix (metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Intercellular Signaling Peptides and Proteins (genetics, metabolism)
  • Interleukin-1beta (metabolism)
  • Matrix Metalloproteinase 2 (genetics, metabolism)
  • Myocytes, Cardiac (metabolism, pathology)
  • Tissue Inhibitor of Metalloproteinase-1 (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Ventricular Remodeling (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: